DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie


Bottcher S, Ritgen M, Fischer K. et al.
Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial.

J Clin Oncol 2012;
30: 980-988

Download Bibliographical Data

Search in: